Dr. Neilsen was a Y-Scholar at Brigham Young University, earning a B.S. in Biochemistry from BYU then a Ph.D. in Experimental Pathology from the University of Utah. He has more than 20 years of diverse research experience in phosphoinositides, drug discovery/assay development, and clinical biomarker development. As R&D director, he has led groups responsible for the discovery, development, and release of hundreds of innovative biochemical products. Dr. Neilsen is a co-inventor on several patents, co-author on numerous publications, and has received multiple grants & contracts from three separate NIH Institutes and DoD.

Dr. Ferguson has a B.S. with honors in Chemistry and Oceanography from the University of British Columbia and a Ph.D. in Chemistry from Queens University. He was a Postdoctoral Associate with Prof. Glenn D. Prestwich at the University of Utah focusing on phosphoinositide and phospholipid synthesis. Dr. Ferguson has been with Echelon since 2001 where his experience in phospholipid chemistry allows Echelon to expand its product offerings and constantly improve its operational efficiencies.

Ms. Sauder has been with Echelon Biosciences since 2005. Ms. Sauder has many years of experience in public accounting and auditing in the private business sector. She has Bachelor’s of Science degrees in both Accounting and Business Economics. Ms. Sauder administers all accounting and human resources functions at Echelon and also aides in materials procurement, inventory management, and bulk quotation.